AMPH earnings: real EPS beat/miss history, analyst consensus Hold, P/E 11.29. Updated 2026-07-23.
Amphastar Pharmaceuticals (AMPH) Research Hub
Amphastar Pharmaceuticals (AMPH) trades on NASDAQ, US in the Healthcare (Drug Manufacturers - Specialty & Generic) sector. As of 2026-09-11, shares last closed at 23.78 USD (+3.21%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 11.29, market cap 0.85B. This hub links to the full technical, earnings and options research available for AMPH.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Drug Manufacturers - Specialty & Generic) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 23.78 USD (+3.21%) |
| 52-week range | 18.22 USD – 23.92 USD |
| Trend regime | Range |
| 14-day RSI | 73.7 (Overbought) |
| Trailing P/E | 11.29 |
| Market cap | 0.85B |
| Dividend yield | 0.00% |
Available research for AMPH
Covered Call on AMPH: how it works, illustrative setup around the real 23.78 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on AMPH: how it works, illustrative setup around the real 23.78 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on AMPH: how it works, illustrative setup around the real 23.78 USD price, max profit/loss, breakeven and when to use it. Educational.
AMPH technical analysis: range, last 23.78 USD, RSI 73.7, 52w range 18.22 USD–23.92 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is AMPH in?
Amphastar Pharmaceuticals (AMPH) is classified under Healthcare (Drug Manufacturers - Specialty & Generic), listed on NASDAQ, US.
Is AMPH in an uptrend or downtrend?
As of 2026-09-11, AMPH is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is AMPH's trailing P/E ratio?
AMPH's trailing P/E is 11.29, with a market cap of 0.85B. See the earnings research page for full valuation detail.